Literature DB >> 26509833

Predictive factors for invasive cancer in surgical specimens following an initial diagnosis of ductal carcinoma in situ after stereotactic vacuum-assisted breast biopsy in microcalcification-only lesions.

Hatice Gümüş1, Philippa Mills, David Fish, Metehan Gümüş, Karina Cox, Haresh Devalia, Sue Jones, Peter Jones, Ali R Sever.   

Abstract

PURPOSE: The aim of this study was to determine the incidence of invasive breast carcinoma in patients with preoperative diagnosis of ductal carcinoma in situ (DCIS) by stereotactic vacuum-assisted biopsy (SVAB) performed for microcalcification-only lesions, and to identify the predictive factors of invasion.
METHODS: From 2000 to 2010, the records of 353 DCIS patients presenting with microcalcification-only lesions who underwent SVAB were retrospectively reviewed. The mammographic size of microcalcification cluster, presence of microinvasion within the cores, the total number of calcium specks, and the number of calcium specks within the retrieved core biopsy specimen were recorded. Patients were grouped as those with or without invasion in the final pathologic report, and variables were compared between the two groups.
RESULTS: The median age was 58 years (range, 34-88 years). At histopathologic examination of the surgical specimen, 63 of 353 patients (17.8%) were found to have an invasive component, although SVAB cores had only shown DCIS preoperatively. The rate of underestimation was significantly higher in patients with microcalcification covering an area of 40 mm or more, in the presence of microinvasion at biopsy, and in cases where less than 40% of the calcium specks were removed from the lesion.
CONCLUSION: Invasion might be underestimated in DCIS cases diagnosed with SVAB performed for microcalcification-only lesions, especially when the mammographic size of calcification is equal to or more than 40 mm or if microinvasion is found within the biopsy specimen and less than 40% of the calcifications are removed. At least 40% of microcalcification specks should be removed from the lesion to decrease the rate of underestimation with SVAB.

Entities:  

Mesh:

Year:  2016        PMID: 26509833      PMCID: PMC4712894          DOI: 10.5152/dir.2015.14453

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  26 in total

1.  The practical application of the UK 5-point scoring system for breast imaging: how standardisation of reporting supports the multidisciplinary team.

Authors:  L S Wilkinson; N T F Ridley
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.

Authors:  R J Jackman; F Burbank; S H Parker; W P Evans; M C Lechner; T R Richardson; A A Smid; H B Borofsky; C H Lee; H M Goldstein; K J Schilling; A B Wray; R F Brem; T H Helbich; D E Lehrer; S J Adler
Journal:  Radiology       Date:  2001-02       Impact factor: 11.105

3.  Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features.

Authors:  Hee Jung Shin; Hak Hee Kim; Sun Mi Kim; Gui Young Kwon; Gyungyub Gong; On Koo Cho
Journal:  AJR Am J Roentgenol       Date:  2008-02       Impact factor: 3.959

4.  Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up.

Authors:  R J Jackman; K W Nowels; J Rodriguez-Soto; F A Marzoni; S I Finkelstein; M J Shepard
Journal:  Radiology       Date:  1999-03       Impact factor: 11.105

5.  Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?

Authors:  C H Lee; D Carter; L E Philpotts; M E Couce; L J Horvath; R C Lange; I Tocino
Journal:  Radiology       Date:  2000-11       Impact factor: 11.105

6.  Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices.

Authors:  R F Brem; J M Schoonjans; S N Goodman; A Nolten; F B Askin; O M Gatewood
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

7.  Percutaneous removal of malignant mammographic lesions at stereotactic vacuum-assisted biopsy.

Authors:  L Liberman; D D Dershaw; P P Rosen; E A Morris; A F Abramson; P I Borgen
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

8.  Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice.

Authors:  M J Silverstein; J R Waisman; P Gamagami; E D Gierson; W J Colburn; R J Rosser; P S Gordon; B S Lewinsky; A Fingerhut
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

9.  Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy.

Authors:  L Liberman; J H Smolkin; D D Dershaw; E A Morris; A F Abramson; P P Rosen
Journal:  Radiology       Date:  1998-07       Impact factor: 11.105

10.  To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy?

Authors:  Laura Liberman; Jennifer B Kaplan; Elizabeth A Morris; Andrea F Abramson; Jennifer H Menell; D David Dershaw
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.